AU1677095A - Oral dosage form of desmopressin (ddavp) - Google Patents

Oral dosage form of desmopressin (ddavp)

Info

Publication number
AU1677095A
AU1677095A AU16770/95A AU1677095A AU1677095A AU 1677095 A AU1677095 A AU 1677095A AU 16770/95 A AU16770/95 A AU 16770/95A AU 1677095 A AU1677095 A AU 1677095A AU 1677095 A AU1677095 A AU 1677095A
Authority
AU
Australia
Prior art keywords
ddavp
desmopressin
dosage form
oral dosage
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16770/95A
Inventor
Howard Bernstein
Mary Dibiase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alkermes Controlled Therapeutics Inc
Original Assignee
Alkermes Inc
Alkermes Controlled Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkermes Inc, Alkermes Controlled Therapeutics Inc filed Critical Alkermes Inc
Publication of AU1677095A publication Critical patent/AU1677095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
AU16770/95A 1994-01-11 1995-01-09 Oral dosage form of desmopressin (ddavp) Abandoned AU1677095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18014294A 1994-01-11 1994-01-11
US180142 1994-01-11
PCT/US1995/000275 WO1995018602A1 (en) 1994-01-11 1995-01-09 ORAL DOSAGE FORM OF DESMOPRESSIN (dDAVP)

Publications (1)

Publication Number Publication Date
AU1677095A true AU1677095A (en) 1995-08-01

Family

ID=22659362

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16770/95A Abandoned AU1677095A (en) 1994-01-11 1995-01-09 Oral dosage form of desmopressin (ddavp)

Country Status (2)

Country Link
AU (1) AU1677095A (en)
WO (1) WO1995018602A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DE10332160A1 (en) 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multiparticulate dosage form containing mucoadhesively formulated peptide or protein active substances, and a method for producing the dosage form
EP1500390B1 (en) 2003-07-25 2005-08-17 Ferring B.V. Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
EP1550439B1 (en) * 2003-12-29 2006-03-08 Ferring B.V. Method for preparing a solid dosage form of desmopressin
CA2490601C (en) * 2003-12-29 2006-05-02 Ferring B.V. Method for preparing solid dosage form of desmopressin
ES2653568T3 (en) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Drug formulations for abuse prevention
US9539302B2 (en) 2009-06-18 2017-01-10 Allergan, Inc. Safe desmopressin administration
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
DE102014103271B4 (en) 2014-03-12 2015-10-01 David Plattner Wire saw apparatus and use of a wire saw device
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006286A1 (en) * 1989-11-06 1991-05-16 Enzytech, Inc. Method for producing protein microspheres
DE59307073D1 (en) * 1992-01-17 1997-09-11 Alfatec Pharma Gmbh PELLETS CONTAINING PEPTIC DRUGS AND THEIR PRODUCTION AND USE THEREOF

Also Published As

Publication number Publication date
WO1995018602A1 (en) 1995-07-13

Similar Documents

Publication Publication Date Title
EG24077A (en) Oral 2-methyl-thieno-benzodiazepine formulation
HUP9603064A2 (en) New oral pharmaceutical dosage form
IL122746A (en) Pharmaceutical formulations containing darifenacin
HUP9903407A3 (en) Oral pharmaceutical preparation containing ibandronat
IL122605A0 (en) Inhaler
IL122758A0 (en) Inhaler
AU3280297A (en) Nasal administration of desmopressin
SG46737A1 (en) Oral formulations of s(+) - etodolac
GB9507133D0 (en) Inhaler
AU1677095A (en) Oral dosage form of desmopressin (ddavp)
IL120673A0 (en) Oral cyclosporin formulations
NZ307236A (en) Preparation of streptogramins
GB9614672D0 (en) Oral airway tube
CA71510S (en) Oral inhaler
AUPM590295A0 (en) Manufacture of pharmaceutical dosage forms
GB9407647D0 (en) Oral medicament
AUPN301495A0 (en) Oral delivery of peptides
HUT75383A (en) Medicinal cigarette